During her MIT years, Juliana Chan could often be found at a lab bench, researching nanoparticle drug delivery technologies, or blogging on her laptop, reporting news about the Asian scientific community.
Today, back in her native Singapore, Chan has scaled up both activities to impressive levels. A fellowship at the city-state’s Agency for Science, Technology, and Research led her to an assistant professorship and a $750,000 startup grant to open her own multidisciplinary lab at Nanyang Technological University’s School of Chemical and Biomedical Engineering and Lee Kong Chian School of Medicine.
And her blog, with an investment from a major scientific publishing company, has evolved into Asian Scientist magazine. The glossy quarterly journal offers in-depth coverage of biotechnology, pharmaceuticals, materials science, and other disciplines, with Chan as editor in chief.
“I’ve always liked writing and been a fangirl of magazines like MIT Technology Review and Scientific American,” says Chan, who earned her BA and MA in natural sciences at the University of Cambridge. “I noticed that no one was writing about great Asian scientists, even though there’s so much hunger for knowledge in Asian countries. I have no journalism training, so it’s crazy that I have a magazine, but it really makes me happy.”
Meanwhile, Chan’s six-person research team is pursuing the use of nanoparticles to treat cardiovascular and skin diseases—work inspired by her PhD studies in the biotech-materials lab of Institute Professor Robert Langer, ScD ’74, and her postdoc work in biological engineering with Professor Roger Kamm, SM ’73, PhD ’77.
The dermatological work is especially important in Asia, she notes, “because conditions like eczema and psoriasis are very common and the current standard of care is steroid creams, which can thin the skin.” Nanoparticles could deliver greatly reduced dosages directly to inflamed tissue, leading to better results with lower risk.
Honors have been numerous—Chan has received a L’Oréal-UNESCO For Women in Science Award and a Singapore Youth Award, and she was recently accepted into the World Economic Forum’s Young Global Leaders. She was also named to MIT Technology Review’s 2014 regional Innovators Under 35 and now serves as a judge for the program.
Chan met her husband, Chester Drum, at the Langer Lab, where he was a postdoc; he’s now a cardiology consultant and assistant professor at the National University of Singapore. Chan says that since the 2013 birth of their daughter, Heather, “we have no leisure time, but I don’t care because I love playing with her so much.”
The inside story of how ChatGPT was built from the people who made it
Exclusive conversations that take us behind the scenes of a cultural phenomenon.
ChatGPT is about to revolutionize the economy. We need to decide what that looks like.
New large language models will transform many jobs. Whether they will lead to widespread prosperity or not is up to us.
Sam Altman invested $180 million into a company trying to delay death
Can anti-aging breakthroughs add 10 healthy years to the human life span? The CEO of OpenAI is paying to find out.
GPT-4 is bigger and better than ChatGPT—but OpenAI won’t say why
We got a first look at the much-anticipated big new language model from OpenAI. But this time how it works is even more deeply under wraps.
Get the latest updates from
MIT Technology Review
Discover special offers, top stories, upcoming events, and more.